Skip to main content
logo
Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
3.040
-0.170 (-5.30%)
At close: Oct 16, 2026, 4:00 PM EDT
3.020
-0.020 (-0.66%)
After-hours: Oct 16, 2026, 7:30 PM EDT

Liminatus Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4178075349337
Market Cap Growth
-87.53%-79.39%6.12%-78.38%3.48%-
Enterprise Value
3179789--
Last Close Price
3.0430.50561.00516.50506.00489.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
11.32-1.68-4.14-4.78-32.30-29.64

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
4.80-0.15-1.03-1.02-1.53-1.16
Net Debt / Equity Ratio
-5.24-0.11-1.03-0.99-1.06-1.16
Net Debt / EBITDA Ratio
0.39-0.37---4.23-3.30
Net Debt / FCF Ratio
0.40-0.11-13.73-4.67-13.18-78.47
Quick Ratio
0.990.030.000.030.290.00
Current Ratio
1.120.050.210.120.390.19
Return on Assets (ROA)
-95.65%-62.65%-54.41%-66.30%-35.51%-
Return on Capital Employed (ROCE)
-1119.00%30.30%17.20%30.50%25.10%35.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-306.69%-61.82%-4.43%-6.60%-0.84%-1.66%
FCF Yield
-97.61%-60.43%-1.81%-4.43%-0.25%-0.05%
Buyback Yield / Dilution
-82.95%-35.73%82.93%-188.25%--
SEC Filings: 10-K · 10-Q